Recurrent bleeding in patients with atrial fibrillation receiving anticoagulation: fundamental and promising aspects of research
- 15 May 2026
- journal article
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 21 (2) , 22-29
Abstract
The review discusses the problem of recurrent bleeding in patients with atrial fibrillation receiving anticoagulant therapy. Anticoagulation determines prognosis of life in patients with atrial fibrillation by preventing ischemic stroke and systemic embolisms. However, at least 15-20% of patients suffer recurrent hemorrhagic complications despite correction of all risk factors and anticoagulation changes. Searching for predictors of recurrent bleeding is extremely relevant, as there is currently no system for stratifying the risk of recurrent hemorrhagic complications. The review analyzes clinical data on the incidence of recurrent bleeding and systematizes risk factors. Some clinical risk factors are unmodifiable that leads to searching for laboratory markers. The review also highlights new possible mechanisms that are promising for study. Data of modern methods of fibrin structure visualization are presented. These findings confirm hypothesis of “unstable” clot as the cause of recurrent bleeding. Data on relationship between gene polymorphism and level of factors determining structure and stability of fibrin (factor XIII, alpha, beta, gamma chains of fibrinogen and fibrinolysis system) are presented.Keywords
This publication has 42 references indexed in Scilit:
- Understanding blood clot mechanical stability: the role of factor XIIIa-mediated fibrin crosslinking in rupture resistanceResearch and Practice in Thrombosis and Haemostasis, 2025
- Protofibril packing density of individual fibers alters fibrinolysisResearch and Practice in Thrombosis and Haemostasis, 2025
- Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world dataEuropean Journal of Clinical Pharmacology, 2022
- Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort StudyClinical Gastroenterology and Hepatology, 2022
- Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Chronic Kidney Disease and Dialysis Patients: A Systematic Review and Meta-AnalysisClinical Drug Investigation, 2021
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial FibrillationJACC, 2019
- Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialAmerican Heart Journal, 2017
- Fibrin Formation, Structure and Properties2017
- Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-lifeInternational Journal of Cardiology, 2017
- The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation studyThe Lancet, 2016